fashion -WSS

fashion

author：entertainment 2025-08-23 08:57:44 - browse：6394

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Deliver public health messages at the right time

hotspot

WSS

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

AltruBio raises $225 million to develop ulcerative colitis drug

Eli Lilly, Pfizer, and others want in on the online prescription market

AltruBio raises $225 million to develop ulcerative colitis drug

As health system earnings go up, health insurance stocks go down

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Wikipedia

fashion

entertainment

Medical records are filled with copy

Is it ever OK for doctors to lie to their patients?

New air purifier tech could be key to improving indoor air quality

Independent physicians launch a new lobbying group

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Black vets could get higher VA benefits if race not used in lung test

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Test for long Covid? Researchers find new clue in blood samples

Drug repurposing or repositioning? The language matters

Humana cuts profit projections as Medicare Advantage costs soar

knowledge

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

How a small hospital in rural Puerto Rico survived Hurricane Maria

Sepsis can kill a child within hours. Here's how hospitals are fighting back

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Francis Collins on trust in science and how Covid communications failed

Crowdfunding for medical bills sidesteps core problem, author says

leisure time

Wikipedia

hotspot

hotspot